source
- 9 biotechs will cut at least half their California workforcesWorkforce reductions have hit over 1,000 biopharma employees in The Golden State year to date, with pink slips coming from small biotechs and large pharmas. Biotechs have been hit the hardest, with…BioSpace · 1h ago↗ source
- Ramping up: 3 biotechs growing their workforce after series C raisesBiotechs that announced series C financing this year and are hiring include one that secured $140 million and has locations in London and Massachusetts.BioSpace · 1h ago↗ source
- GSK receives FDA accelerated approval for neladalkib (Nelkarmi) in ALK-positive lung cancer, second win from Nuvalent dealGSK announced that the FDA has granted accelerated approval to its tyrosine kinase inhibitor neladalkib, to be sold under the brand name Nelkarmi, for patients with ALK‑positive non‑small cell lung…